Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

This study has been completed.
Korea Otsuka Pharmaceutical Co.,Ltd.
Information provided by (Responsible Party):
Kyooseob Ha, Seoul National University Bundang Hospital Identifier:
First received: February 14, 2009
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)